{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:48:12Z","timestamp":1768708092682,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"FWO-Flanders, Belgium","doi-asserted-by":"publisher","award":["G.0173.09N"],"award-info":[{"award-number":["G.0173.09N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"IWT, Belgium","doi-asserted-by":"publisher","award":["SBO 50164"],"award-info":[{"award-number":["SBO 50164"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Industrial Research Fund of the University of Leuven","award":["IOF\/KP\/09\/003"],"award-info":[{"award-number":["IOF\/KP\/09\/003"]}]},{"name":"NEUROPRO","award":["223077"],"award-info":[{"award-number":["223077"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejmech.2017.08.024","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T15:16:20Z","timestamp":1502378180000},"page":"482-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling"],"prefix":"10.1016","volume":"139","author":[{"given":"Dean","family":"Rea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roos","family":"Van Elzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"De Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan","family":"Van Goethem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Landuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Schoofs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Van Der Veken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Augustyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-0124","authenticated-orcid":false,"given":"Ingrid","family":"De Meester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilmos","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-3777","authenticated-orcid":false,"given":"Anne-Marie","family":"Lambeir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.08.024_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2012.02579.x","article-title":"Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen","volume":"333","author":"Bostanci","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-302X.2009.00544.x","article-title":"Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque","volume":"24","author":"Byrne","year":"2009","journal-title":"Oral Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijcard.2009.10.034","article-title":"Porphyromonas gingivalis (Pg) a possible link between impaired oral health and acute myocardial infarction","volume":"148","author":"Holmlund","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.AOG.0000190212.87012.96","article-title":"Progressive periodontal disease and risk of very preterm delivery","volume":"107","author":"Offenbacher","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"137 Suppl","key":"10.1016\/j.ejmech.2017.08.024_bib5","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.14219\/jada.archive.2006.0400","article-title":"Pneumonia in nonambulatory patients. The role of oral bacteria and oral hygiene","author":"Scannapieco","year":"2006","journal-title":"J.\u00a0Am. Dent. Assoc."},{"key":"10.1016\/j.ejmech.2017.08.024_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.micinf.2009.03.009","article-title":"Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?","volume":"11","author":"Hajishengallis","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ejmech.2017.08.024_bib7","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/mic.0.2008\/021220-0","article-title":"The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay","volume":"154","author":"Yilmaz","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.ejmech.2017.08.024_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-0765.2006.00966.x","article-title":"Effect of gamma-immunoglobulin on the asaccharolytic growth of Porphyromonas gingivalis","volume":"42","author":"Oda","year":"2007","journal-title":"J.\u00a0Periodontal Res."},{"key":"10.1016\/j.ejmech.2017.08.024_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1600-0765.2008.01117.x","article-title":"Participation of the secreted dipeptidyl and tripeptidyl aminopeptidases in asaccharolytic growth of Porphyromonas gingivalis","volume":"44","author":"Oda","year":"2009","journal-title":"J.\u00a0Periodontal Res."},{"key":"10.1016\/j.ejmech.2017.08.024_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000181144","article-title":"Corruption of innate immunity by bacterial proteases","volume":"1","author":"Potempa","year":"2009","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.ejmech.2017.08.024_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/IAI.68.2.716-724.2000","article-title":"Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence","volume":"68","author":"Kumagai","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2017.08.024_bib12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/IAI.68.3.1176-1182.2000","article-title":"Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV","volume":"68","author":"Banbula","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2017.08.024_bib13","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/IAI.73.5.2655-2664.2005","article-title":"Molecular mechanism for connective tissue destruction by dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis","volume":"73","author":"Kumagai","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2017.08.024_bib14","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1128\/IAI.69.11.7159-7161.2001","article-title":"Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant","volume":"69","author":"Yagishita","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2017.08.024_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1348-0421.2003.tb03443.x","article-title":"Peptidase activity of dipeptidyl aminopeptidase IV produced by Porphyromonas gingivalis is important but not sufficient for virulence","volume":"47","author":"Kumagai","year":"2003","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/2049-632X.12156","article-title":"Importance of biofilm formation and dipeptidyl peptidase IV for the pathogenicity of clinical Porphyromonas gingivalis isolates","volume":"70","author":"Clais","year":"2014","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.ejmech.2017.08.024_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/0-306-47920-6_3","article-title":"Exploration of the active site of dipeptidyl peptidase IV from Porphyromonas gingivalis. Comparison with the human enzyme","volume":"524","author":"Lambeir","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1107\/S0907444904017639","article-title":"Expression, purification and preliminary crystallographic analysis of dipeptidyl peptidase IV from Porphyromonas gingivalis","volume":"60","author":"Rea","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"Nauck","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejmech.2017.08.024_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/jm981033g","article-title":"Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors","volume":"42","author":"Belyaev","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/C5MD00454C","article-title":"Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation","volume":"7","author":"Heirbaut","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2017.08.024_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib23","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/jm500031w","article-title":"Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)","volume":"57","author":"Jansen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0304-4165(96)00012-8","article-title":"Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV","volume":"1290","author":"Lambeir","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2017.08.024_bib25","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.bmcl.2012.03.107","article-title":"Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP\/prolyl oligopeptidase (PREP)-selectivity","volume":"22","author":"Ryabtsova","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib26","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0960-894X(02)00603-0","article-title":"Development of potent and selective dipeptidyl peptidase II inhibitors","volume":"12","author":"Senten","year":"2002","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib27","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/jm031122f","article-title":"Gamma-amino-substituted analogues of 1-[(S)-2,4-diaminobutanoyl]piperidine as highly potent and selective dipeptidyl peptidase II inhibitors","volume":"47","author":"Senten","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib28","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1016\/j.bmcl.2006.06.082","article-title":"Synthesis and dipeptidyl peptidase inhibition of N-(4-substituted-2,4-diaminobutanoyl)piperidines","volume":"16","author":"Soroka","year":"2006","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib29","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1016\/j.bmcl.2008.05.080","article-title":"Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads","volume":"18","author":"Van der Veken","year":"2008","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib30","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1021\/jm301060g","article-title":"P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy","volume":"55","author":"Van der Veken","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib31","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1021\/jm701005a","article-title":"Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates","volume":"50","author":"Van der Veken","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib32","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1021\/jm200383j","article-title":"Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?","volume":"54","author":"Van Goethem","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib33","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1016\/j.bmcl.2008.05.079","article-title":"Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors","volume":"18","author":"Van Goethem","year":"2008","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.024_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nsb882","article-title":"Crystal structure of human dipeptidyl peptidase IV\/CD26 in complex with a substrate analog","volume":"10","author":"Rasmussen","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2013.03.010","article-title":"A\u00a0comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site","volume":"434","author":"Nabeno","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2017.08.024_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1110\/ps.073253208","article-title":"Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation","volume":"17","author":"Metzler","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2017.08.024_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/abbi.1995.0020","article-title":"Aminoacylpyrrolidine-2-nitriles: potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26)","volume":"323","author":"Li","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2017.08.024_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcp.2005.04.009","article-title":"Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile)","volume":"70","author":"Brandt","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib39","first-page":"8","article-title":"Ligand-induced conformational changes in prolyl oligopeptidase: a kinetic approach","volume":"30","author":"Van Elzen","year":"2017","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ejmech.2017.08.024_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/prot.21138","article-title":"Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site","volume":"66","author":"Rummey","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2017.08.024_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00395-013-0350-4","article-title":"Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis","volume":"108","author":"Matheeussen","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10753-015-0263-5","article-title":"The dipeptidyl peptidases 4, 8, and 9 in mouse monocytes and macrophages: DPP8\/9 inhibition attenuates M1 macrophage activation in mice","volume":"39","author":"Waumans","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2017.08.024_bib43","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/JB.02010-07","article-title":"Dipeptidyl aminopeptidase IV from Stenotrophomonas maltophilia exhibits activity against a substrate containing a 4-hydroxyproline residue","volume":"190","author":"Nakajima","year":"2008","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1186\/1471-2164-15-985","article-title":"Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages","volume":"15","author":"Kaushik","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ejmech.2017.08.024_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-60761-535-4_15","article-title":"Identification and relative quantification of neuropeptides from the endocrine tissues","volume":"615","author":"Boonen","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-1-60761-535-4_25","article-title":"Bioinformatic approaches to the identification of novel neuropeptide precursors","volume":"615","author":"Clynen","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"[20] Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1107\/S0909049503023938","article-title":"SOLVE and RESOLVE: automated structure solution, density modification and model building","volume":"11","author":"Terwilliger","year":"2004","journal-title":"J.\u00a0Synchrotron Radiat."},{"key":"10.1016\/j.ejmech.2017.08.024_bib50","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1107\/S0907444906022116","article-title":"The Buccaneer software for automated model building. 1. Tracing protein chains","volume":"62","author":"Cowtan","year":"2006","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1107\/S0021889809042022","article-title":"The MORPHEUS protein crystallization screen","volume":"42","author":"Gorrec","year":"2009","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib53","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"N. Collaborative Computational Project","year":"1994","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2017.08.024_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.ejmech.2017.08.024_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/8263","article-title":"Automated protein model building combined with iterative structure refinement","volume":"6","author":"Perrakis","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2017.08.024_bib57","series-title":"DeLano Scientific, Palo Alto, CA","article-title":"The PyMOL user's manual","author":"DeLano","year":"2002"},{"key":"10.1016\/j.ejmech.2017.08.024_bib58","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1021\/jm400351a","article-title":"Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase","volume":"56","author":"Poplawski","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/jm0493156","article-title":"(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"48","author":"Kim","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib60","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2337\/diabetes.54.10.2988","article-title":"Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9","volume":"54","author":"Lankas","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2017.08.024_bib61","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1021\/jm701280z","article-title":"8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylme thyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes","volume":"50","author":"Eckhardt","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.024_bib62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1107\/S0907444998012645","article-title":"Remarks about protein structure precision","volume":"55","author":"Cruickshank","year":"1999","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.024_bib63","doi-asserted-by":"crossref","first-page":"e0157509","DOI":"10.1371\/journal.pone.0157509","article-title":"Trelagliptin (SYR-472, Zafatek), novel once-weekly treatment for type 2 diabetes, inhibits dipeptidyl Peptidase-4 (DPP-4) via a non-covalent mechanism","volume":"11","author":"Grimshaw","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.08.024_bib64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1107\/S0108767386099622","article-title":"Improved Fourier coefficients for maps using phases from partial structures with errors","volume":"42","author":"Read","year":"1986","journal-title":"Acta Crystallogr. A Found. Adv."},{"key":"10.1016\/j.ejmech.2017.08.024_bib65","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/jm060015t","article-title":"(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]tr iazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"49","author":"Edmondson","year":"2006","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341730627X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341730627X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T12:28:58Z","timestamp":1535459338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341730627X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":65,"alternative-id":["S022352341730627X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.024","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}